23 products were found matching "K08413"!

Description: ML192 (CID1434953) is a selective GPR55 ligand antagonist. ML192 is an inhibitor that inhibits beta-arrestin transport, ERK1/2 phosphorylation, and PKCbetaII translocation. Target: GPR, Cannabinoid Receptor, Arrestin. Smiles: Cc1nc(N2CCN(CC2)C(=O)c2ccco2)c2c3CCCCc3sc2n1. References: Kotsikorou E, et...

Description: CID 16020046 (C390-0219) is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 µM in yeast. Target: Cannabinoid Receptor. Smiles: Cc1ccc(cc1)-c1n[nH]c2C(=O)N(C(c12)c1cccc(O)c1)c1ccc(cc1)C(O)=O. References: Kargl J, et al. A selective antagonist reveals a potential...

Recombinant human GPR55(1-21) protein with C-terminal human Fc tag. GPR55(Met1-Thr21) hFc(Glu99-Ala330), Protein function: May be involved in hyperalgesia associated with inflammatory and neuropathic pain. Receptor for L-alpha- lysophosphatidylinositol (LPI). LPI induces Ca(2+) release from intracellular stores via...

Discover a breakthrough in membrane protein research and drug development with DIMA Biotech's Synthetic Nanodiscs. Traditional methods struggle with challenges in obtaining water-soluble and bioactive forms of multi-transmembrane proteins. Our innovative polymer-based Nanodisc platform offers a game-changing...

ML-193 is a potent antagonist of GPR55 (IC50 = 221 nM). It displays selectivity for GPR55 over CB1, CB2, and GPR35. ML-193 inhibits GPR55-dependent ERK phosphorylation (IC50 = 65 nM) and blocks translocation of PKCbetaII. ML-193 blocks increases in intracellular calcium levels induced by lysophosphatidylinositol...

GPR55 is a G protein-coupled receptor that is weakly activated by some cannabinoids (CBs) at nM concentrations but displays a 5- to 10-fold greater stimulation in response to 1 µM lysophosphatidylinositol (LPI). ML-184 is a potent synthetic agonist of GPR55 (EC50 = 0.26 µM). It does not act at the related kynurenic...

CID-16020046 is a GPR55 inverse agonist that antagonizes GPR55 constitutive activity with an IC50 value of 15 µM. It inhibits GPR55-mediated ERK1/2 phosphorylation, LPI-induced Ca2+ signaling (IC50 = 0.21 µM in HEK-GPR55 cells), and GPR55-mediated transcription factor activation. It does not affect ERK1/2...

GPR55 is an orphan G protein-coupled receptor. GPR55 is expressed in the brain, large dorsal root ganglion neurons, and many peripheral tissues. Endogenous agonists for GPR55 include lysophosphatidylinositol (EC50 = 1.2 µM in a beta-arrestin-GFP biosensor assay) and the endocannabinoids anandamide (arachidonoyl...

ML-192 is an antagonist of GPR55 (IC50 = 702 nM). It is selective for GPR55 over the cannabinoid (CB) receptors CB1 and CB2, as well as GPR35 (IC50s = >32 µM).Formal Name: 2-furanyl[4-(5,6,7,8-tetrahydro-2-methyl[1]benzothieno[2,3-d]pyrimidin-4-yl)-1-piperazinyl]-methanone. CAS Number: 460331-61-7. Synonyms:...

This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. Protein function: May be involved in hyperalgesia...

This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. Protein function: May be involved in hyperalgesia...

This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. Protein function: May be involved in hyperalgesia...